Conversely, in other tumor types, such as hepatocellular carcinoma, agents like ketoconazole and sorafenib paradoxically promote mitophagy through the stabilization of PINK1 and recruitment of parkin, which can culminate in apoptotic cell death [191]. The gene discussed is PRKN; the disease is hepatocellular carcinoma.